Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Anti-infection
    (1)
  • Antibacterial
    (1)
  • Antibiotic
    (1)
  • Antifungal
    (1)
  • Antiviral
    (1)
  • Apoptosis
    (1)
  • EGFR
    (1)
  • HER
    (1)
  • MMP
    (1)
  • Others
    (3)
TargetMol | Tags By ResearchField
  • Infection
    (3)
  • Immune System
    (2)
  • Inflammation
    (2)
  • Cancer
    (1)
Filter
Search Result
Results for "

T2630

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    6
    TargetMol | All_Pathways
  • Natural Products
    1
    TargetMol | Natural_Products
Poziotinib
NOV120101, HM781-36B
T26301092364-38-9
Poziotinib (NOV120101)(NOV120101; HM781-36B) is an irreversible HER1/2/4 inhibitor (IC50s: 3/5/23 nM).
  • $30
In Stock
Size
QTY
TargetMol | Citations Cited
Lipoxamycin hemisulfate
U-26146D, U26146D, U 26146D, Lipoxamycin, sulfate (2:1), Lipoxamycin
T2630811075-87-9In house
Lipoxamycin hemisulfate (Lipoxamycin) is an inhibitor of serine palmitoyltransferase (IC50 = 21 nM) with antifungal activity.
  • $50
In Stock
Size
QTY
Lipoxamycin HCl
Lipoxamycin HCl(11075-87-9 Free base)
T26308LIn house
Lipoxamycin HCl is a potent serine palmitoyltransferase inhibitor with antifungal activity and inhibits serine palmitoyltransferase activity.
  • $218
In Stock
Size
QTY
TYT-1
NSC298213
T2630364803-10-7
TYT-1 is a West Nile virus (WNV) inhibitor exhibiting antiviral activity (IC₅₀ = 0.7 mM) by blocking the pre-assembly replication step following viral entry into cells.
  • $293
In Stock
Size
QTY
U 27391
U-27391, U27391
T26304106314-87-8
U 27391 is a metalloproteinase inhibitor. It acts by inhibits the action of human recombinant interleukin-1beta and glycosaminoglycan synthesis.
  • $1,520
6-8 weeks
Size
QTY
Umirolimus
TRM-986, TRM986, TRM 986, Biolimus-A9, Biolimus A9
T26309851536-75-9
Umirolimus is a sirolimus derivative from a biodegradable polylactic acid polymer. It has enhanced anti-inflammatory and antiproliferative activity with an improved pharmacokinetic profile.
  • $293
35 days
Size
QTY